info icon

Myiasis

AB1_MYIASIS

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 B87
  • Hospital discharge: ICD-9 1340A
  • Hospital discharge: ICD-8 1340
  • Cause of death: ICD-10 B87
  • Cause of death: ICD-9 1340A
  • Cause of death: ICD-8 1340

2 out of 7 registries used, show all original rules.

21

4. Check minimum number of events

None

21

5. Include endpoints

None

21

6. Filter based on genotype QC (FinnGen only)

21

Control definitions (FinnGen only)

Control exclude
AB1_PEDICULOSIS_ACARIASIS_OTHERINFEST

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF5

Case counts by codes

FinnGen case counts by registry codes:

Not enough data for upset plot.

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 176 87 88
Only index persons 149 73 76
Unadjusted period prevalence (%)
Whole population 0.00 0.00 0.00
Only index persons 0.00 0.00 0.00
Median age at first event (years)
Whole population 39.22 41.91 36.56
Only index persons 35.07 40.01 30.32

-FinnGen-

Key figures

All Female Male
Number of individuals 21 12 9
Unadjusted period prevalence (%) 0.00 0.00 0.00
Median age at first event (years) 48.42 41.09 58.21

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

No data available

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3044889) 12 lead EKG panel
8
128
0.40
1.21
5.7
3.6
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
0
31
0.00
1.06
0.0
2.0
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
16
120
2.39
0.97
2.4
4.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
0
25
0.00
0.85
0.0
1.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
0
20
0.00
0.64
0.0
2.1
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
0
19
0.00
0.64
0.0
1.7
—
—
—
0
0
(3013512) EKG study
7
45
1.83
0.57
2.6
4.2
—
—
—
0
0
(3003338) MCHC [Mass/volume]
13
156
0.56
0.52
19.7
16.4
g/l
329.2
332.4
0.52
13
156
(42870588) Differential panel, method unspecified - Blood
8
55
1.73
0.52
9.0
6.0
—
—
—
0
0
(3026782) Osmolality of Urine
5
32
1.73
0.46
1.0
2.7
mosm/kgh2o
423.0
549.1
—
5
26
(3011397) Hemoglobin [Presence] in Urine by Test strip
5
33
1.67
0.45
1.4
4.9
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
0
15
0.00
0.43
0.0
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
0
16
0.00
0.43
0.0
1.9
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
0
18
0.00
0.42
0.0
1.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
0
18
0.00
0.42
0.0
1.7
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
6
41
1.64
0.41
1.3
2.8
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
6
44
1.51
0.39
2.7
3.0
e6/l
0.1
0.7
—
6
29
(3003694) ABO and Rh group [Type] in Blood
6
45
1.46
0.38
1.3
1.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
6
45
1.46
0.38
2.3
2.7
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
10
77
1.57
0.34
3.1
3.6
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
11
132
0.65
0.32
5.7
3.6
mm/h
12.1
9.7
0.66
11
121
(3024561) Albumin [Mass/volume] in Serum or Plasma
6
80
0.65
0.32
9.2
3.0
g/l
35.8
35.2
—
6
72
(40758558) Short blood count panel - Blood
6
46
1.42
0.23
14.0
7.2
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
6
49
1.31
0.23
2.7
3.0
e6/l
1630.2
31.5
—
6
35
(3021440) Promyelocytes/100 leukocytes in Blood
0
11
0.00
0.22
0.0
3.3
—
0.0
—
0
5
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.22
0.0
1.8
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
7
56
1.37
0.22
1.3
3.8
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
0
12
0.00
0.22
0.0
3.3
—
0.5
—
0
6
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
7
57
1.34
0.21
6.3
2.5
u/l
62.3
33.8
—
7
51
(3015736) pH of Urine
7
57
1.34
0.21
1.6
3.9
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
2.8
—
70.6
—
0
13
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
5
65
0.70
0.21
2.2
2.6
ng/l
127.4
58.7
—
5
40
(3017143) Hepatitis C virus Ab [Presence] in Serum
0
14
0.00
0.21
0.0
1.7
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
6
73
0.75
0.20
2.2
2.3
nmol/l
85.8
73.5
—
6
65
(3022096) Basophils/100 leukocytes in Blood
9
77
1.29
0.19
10.8
5.3
%
0.9
0.7
—
9
70
(3018010) Neutrophils/100 leukocytes in Blood
9
78
1.27
0.19
10.9
5.8
%
61.2
57.8
—
9
73
(3006504) Eosinophils/100 leukocytes in Blood
9
79
1.24
0.19
10.8
5.6
%
2.5
2.7
—
9
73
(3019069) Monocytes/100 leukocytes in Blood
9
79
1.24
0.19
10.8
5.9
%
8.9
8.4
—
9
73
(3044640) Blood type and Crossmatch panel - Blood
6
53
1.18
0.10
1.5
2.7
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
7
63
1.17
0.09
3.7
4.8
ug/l
0.7
1.7
—
7
58
(40768804) Tissue Pathology biopsy report
6
71
0.78
0.09
2.5
1.9
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
8
71
1.20
0.09
3.4
6.1
mmol/l
1.2
1.2
—
8
64
(3021589) Normoblasts [#/volume] in Blood
9
82
1.17
0.09
10.3
8.0
e9/l
0.0
0.0
—
9
63
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
13
120
1.22
0.09
1.8
3.4
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
11
105
1.10
0.00
11.2
10.0
e9/l
4.7
4.4
0.23
11
90
(3035637) Corticotropin [Mass/volume] in Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
0
5
0.00
0.00
0.0
2.6
—
214.6
—
0
5
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.0
—
0.0
—
0
5
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
0.2
—
0
5
(3028707) Methadone [Presence] in Urine by Screen method
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
1.1
—
0
5
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.0
—
7.9
—
0
5
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
0
5
0.00
0.00
0.0
1.8
—
90.5
—
0
5
(3026008) Bacteria identified in Urine by Culture
5
47
1.08
0.00
1.6
2.4
—
—
—
0
0
(3020891) Body temperature
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
6
59
1.02
0.00
2.0
3.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
0
6
0.00
0.00
0.0
2.3
—
81.8
—
0
6
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.4
—
241.1
—
0
7
(3024891) Influenza virus A+B Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
7
76
0.88
0.00
2.0
3.1
ug/l
208.8
93.3
—
7
68
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.6
—
17.7
—
0
7
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
50.2
—
0
6
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
0
9
0.00
0.00
0.0
3.0
—
0.0
—
0
9
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
69.4
—
0
6
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
9
91
0.98
0.00
10.9
5.6
e9/l
2.1
1.9
—
9
83
(40768793) Breast Pathology biopsy report
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(1002224) Polysomnography panel
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
15.0
—
24.0
—
0
8
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint AB1_MYIASIS and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have AB1_MYIASIS.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

Index endpoint: AB1_MYIASIS – Myiasis

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data